Sunmax Biotechnology Co., Ltd. (TPEX:4728)
396.00
+6.50 (1.67%)
At close: Mar 9, 2026
Sunmax Biotechnology Market Cap
Sunmax Biotechnology has a market cap or net worth of 21.57 billion as of March 9, 2026. Its market cap has increased by 45.86% in one year.
Market Cap
21.57B
Enterprise Value
20.96B
Revenue
2.00B
Ranking
n/a
PE Ratio
30.11
Stock Price
396.00
Market Cap Chart
Since January 25, 2010, Sunmax Biotechnology's market cap has increased from 1.49B to 21.57B, an increase of 1,350.31%. That is a compound annual growth rate of 18.05%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Polaris Group | 23.58B |
| EirGenix | 18.10B |
| Oneness Biotech | 26.27B |
| Lumosa Therapeutics | 26.36B |
| TaiMed Biologics | 14.62B |
| AP Biosciences | 14.46B |
| TCM Biotech International | 14.02B |
| Lin BioScience | 33.05B |